These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction. Politiek MJ, Boorsma M, Aalbers R. Eur Respir J; 1999 May; 13(5):988-92. PubMed ID: 10414394 [Abstract] [Full Text] [Related]
9. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma. Bjermer L, Rosenborg J, Bengtsson T, Lötvall J. Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810 [Abstract] [Full Text] [Related]
10. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients. Palmqvist M, Ibsen T, Mellén A, Lötvall J. Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407 [Abstract] [Full Text] [Related]
14. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lötvall J. Pulm Pharmacol Ther; 2001 Oct; 14(1):29-34. PubMed ID: 11162416 [Abstract] [Full Text] [Related]
18. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I, Hall IP, McFarlane LC, Lipworth BJ. J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449 [Abstract] [Full Text] [Related]